Biotech · Public company · New York, NY, US
Revium Rx.
Ticker RVRC · SEC CIK 0001839140
Track this companyFree. Adds Revium Rx. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
SEC filings12
- 10-Q · QUARTERLY REPORTSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Jun 22, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Jun 1, 2026 · fetched Nov 12, 2026
- 10-Q · QUARTERLY REPORTSEC EDGAR · filed May 14, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Apr 20, 2026 · fetched Nov 12, 2026
- 10-K · ANNUAL REPORTSEC EDGAR · filed Mar 31, 2026 · fetched Nov 12, 2026
- S-1/A · AMENDMENT NO. 5 TO FORM S-1SEC EDGAR · filed Jan 28, 2026 · fetched Nov 12, 2026
- S-1/A · AMENDMENT NO. 4 TO FORM S-1SEC EDGAR · filed Jan 16, 2026 · fetched Nov 12, 2026
- S-1/A · AMENDMENT NO. 3 TO FORM S-1SEC EDGAR · filed Dec 12, 2025 · fetched Nov 12, 2026
- S-1/A · AMENDMENT NO. 2 TO FORM S-1SEC EDGAR · filed Oct 3, 2025 · fetched Nov 12, 2026
- S-1/A · AMENDMENT NO. 1 TO FORM S-1SEC EDGAR · filed Aug 13, 2025 · fetched Nov 12, 2026
- S-1 · REGISTRATION STATEMENTSEC EDGAR · filed Feb 14, 2025 · fetched Nov 12, 2026